 OncLive | Emerging Markers Point to Future Strategies in CLL: An Interview With William ... OncLive Please discuss your research into fludarabine, cyclophosphamide, and rituximab (FCR)-based treatment for CLL. 1 Assume you have a patient who has developed an indication for treatment. If they have anemia, thrombocytopenia, or fatigue that needs to be ... |
